Delivery Order SPE2DB22D1017-SPE2DB25FG9ML
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,948.56 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $21,080.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with...
- The Defense Logistics Agency awarded a $37,622.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine in adults and represents one of many...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order valued at $9,418.24 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This competitively awarded, non-set-aside delivery order is scheduled for completion by August 8, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,906.04 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. NURTEC ODT is a migraine treatment medication, reflecting the range of pharmaceutical products that AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $16,075.41 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This competitively awarded, firm fixed-price delivery order is set to be completed by August 6, 2025, and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a branded pharmaceutical product used for migraine treatment, representing one component of...
- The Defense Logistics Agency awarded a delivery order valued at $10,459.96 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count). This competitively awarded, firm fixed-price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. NURTEC ODT is a migraine treatment medication, reflecting the company's...
- The Defense Logistics Agency awarded a $47,367.48 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. NURTEC ODT is a prescription medication used for the acute treatment of migraine, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $21,555.14 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 8, 2025. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 11, 2025 and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment, representing a pharmaceutical supply delivery under the federal medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9MLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,344.93 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract calls for the supply of NURTEC ODT, a prescription medication indicated for migraine treatment, supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to deliver an extensive portfolio of medications and medical supplies to military healthcare programs, the Defense Health Agency, the U.S. Coast Guard, and other federal healthcare systems worldwide. The company's federal contract history demonstrates consistent capability in competitively delivering pharmaceutical products across multiple therapeutic domains with firm fixed pricing arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 8/11/25 |